Protara Therapeutics (TARA) News Today $2.31 -0.01 (-0.43%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period FY2024 EPS Forecast for Protara Therapeutics Cut by AnalystNovember 19 at 1:17 AM | americanbankingnews.comWhat is HC Wainwright's Forecast for TARA FY2024 Earnings?Protara Therapeutics, Inc. (NASDAQ:TARA - Free Report) - Equities researchers at HC Wainwright reduced their FY2024 earnings per share estimates for Protara Therapeutics in a note issued to investors on Thursday, November 14th. HC Wainwright analyst A. Fein now expects that the company will earnNovember 18 at 1:12 AM | marketbeat.comProtara Therapeutics, Inc. (NASDAQ:TARA) Sees Large Increase in Short InterestProtara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 2,740,000 shares, an increase of 18.1% from the October 15th total of 2,320,000 shares. Based on an average trading volume of 179,100 shares, the days-to-cover ratio is currently 15.3 days.November 16, 2024 | marketbeat.comProtara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic OncologyNovember 15, 2024 | globenewswire.comProtara Therapeutics (NASDAQ:TARA) Stock, Option ChainNovember 14, 2024 | benzinga.comHC Wainwright Reaffirms "Buy" Rating for Protara Therapeutics (NASDAQ:TARA)HC Wainwright restated a "buy" rating and issued a $23.00 target price on shares of Protara Therapeutics in a research note on Thursday.November 14, 2024 | marketbeat.comProtara Therapeutics Reports Increased R&D ExpensesNovember 14, 2024 | markets.businessinsider.comOppenheimer Sticks to Their Buy Rating for Protara Therapeutics (TARA)November 13, 2024 | markets.businessinsider.comProtara Therapeutics sees cash runway into 2026November 13, 2024 | markets.businessinsider.comProtara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business UpdateNovember 13, 2024 | markets.businessinsider.comProtara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNovember 6, 2024 | globenewswire.comProtara Therapeutics Announces Fast Track Designation For Intravenous Choline ChlorideOctober 21, 2024 | markets.businessinsider.comProtara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral SupportOctober 21, 2024 | globenewswire.comProtara Therapeutics (NASDAQ:TARA) Stock, Insider Trading ActivityOctober 7, 2024 | benzinga.comProtara Therapeutics (NASDAQ:TARA) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comInsider Selling: Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells 32,600 Shares of StockSeptember 13, 2024 | insidertrades.comAnalysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)September 12, 2024 | markets.businessinsider.comOpaleye Management Inc. Reduces Stake in Protara Therapeutics Inc.September 12, 2024 | finance.yahoo.comInsider Selling: Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells 36,492 Shares of StockSeptember 11, 2024 | insidertrades.comProtara Reports Study Results On Choline Deficiency, Liver Injury In Patients On Parenteral SupportSeptember 10, 2024 | markets.businessinsider.comProtara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic MalformationsSeptember 9, 2024 | globenewswire.comProtara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral SupportSeptember 9, 2024 | globenewswire.comProtara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comProtara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business UpdateAugust 6, 2024 | finance.yahoo.comProtara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells $27,806.24 in StockJuly 19, 2024 | insidertrades.comInsider Selling: Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells 8,497 Shares of StockJuly 12, 2024 | insidertrades.comProtara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells $17,570.56 in StockJuly 4, 2024 | insidertrades.comProtara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Opaleye Management Inc. Sells 46,574 SharesJune 29, 2024 | insidertrades.comOpaleye Management Inc. Sells 12,725 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) StockJune 29, 2024 | insidertrades.comProtara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)June 24, 2024 | globenewswire.comProtara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Opaleye Management Inc. Sells 9,230 SharesJune 1, 2024 | insidertrades.comProtara Therapeutics, Inc. (NASDAQ:TARA) Short Interest UpdateProtara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 1,360,000 shares, a growth of 32.0% from the April 30th total of 1,030,000 shares. Based on an average daily volume of 381,100 shares, the days-to-cover ratio is currently 3.6 days.May 31, 2024 | marketbeat.comInsider Selling: Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells 33,000 Shares of StockMay 24, 2024 | insidertrades.comProtara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Opaleye Management Inc. Sells 33,000 SharesProtara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) major shareholder Opaleye Management Inc. sold 33,000 shares of the firm's stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $3.06, for a total value of $100,980.00. Following the transaction, the insider now directly owns 124,250 shares in the company, valued at approximately $380,205. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.May 23, 2024 | marketbeat.comProtara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation SummitMay 21, 2024 | globenewswire.comInsider Selling: Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells 70,885 Shares of StockMay 18, 2024 | insidertrades.comOpaleye Management sells shares in Protara Therapeutics for $567kMay 12, 2024 | investing.comInsider Selling: Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells 30,600 Shares of StockMay 11, 2024 | insidertrades.comBuy Rating Affirmed for Protara Therapeutics Amid Promising Clinical Trials and Market Potential for TARA-002May 7, 2024 | markets.businessinsider.comTARA Stock Earnings: Protara Therapeutics Misses EPS for Q1 2024May 2, 2024 | investorplace.comProtara Therapeutics: Q1 Earnings SnapshotMay 2, 2024 | sfgate.comProtara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business UpdateMay 2, 2024 | globenewswire.comProtara Therapeutics (TARA) Price Target Decreased by 11.76% to 27.54April 17, 2024 | msn.comProtara Therapeutics, Inc. (TARA)April 15, 2024 | finance.yahoo.comBuy Rating for Protara Therapeutics’ TARA-002 Based on Promising Clinical Data and Market Potential in NMIBC TreatmentApril 9, 2024 | markets.businessinsider.comProtara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via EquityApril 5, 2024 | msn.comProtara Reaches Alignment With FDA On A Registrational Path Forward For IV Choline ChlorideApril 5, 2024 | markets.businessinsider.comProtara Announces Positive Data From TARA-002 Trial In Bladder Cancer; Stock UpApril 5, 2024 | markets.businessinsider.comProtara Therapeutics Announces Oversubscribed $45 Million Private Placement FinancingApril 5, 2024 | globenewswire.comProtara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral NutritionApril 5, 2024 | globenewswire.com Get Protara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TARA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. TARA Media Mentions By Week TARA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TARA News Sentiment▼0.120.45▲Average Medical News Sentiment TARA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TARA Articles This Week▼111▲TARA Articles Average Week Get Protara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TARA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CSBR News ADCT News CMPX News HRTX News INZY News TNYA News NBTX News CRBU News KYTX News SCPH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TARA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TARA Stock Alerts